Themis, a collaborative governance, risk, and compliance platform, recently announced thatit has secured $9 million in seed investment “to solve compliance and risk challenges stemming from ...

Themis Bioscience has postponed its planned IPO in Amsterdam. The Austrian biotech is now looking into “all strategic options” to secure the cash it needs to move its chikungunya vaccine into phase 3.

Abu Dhabi, UAE – AI and Anti-Financial Crime pioneer Themis, a certified B-Corp, today announced the launch of AI Investigator — an intelligent LLM-driven due diligence platform designed to transform ...

OIRSCHOT, The Netherlands--(BUSINESS WIRE)--The Robot and Autonomous Systems (RAS) Unit of the 13th Light Brigade of the Royal Netherlands Army received two THeMIS unmanned ground vehicles developed ...